There is now a growing awareness of the central role of platelet function in microvascular thrombosis. Platelet aggregation studies remain one of the most useful ways of studying platelet function and response to different stimuli. This brief communication highlights some of the main variables that
In vitro inhibition of rat platelet aggregation by ochratoxin A
β Scribed by Omar, Rabeea F. ;Randell, Edward ;Rahimtula, Anver D.
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 680 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0887-2082
No coin nor oath required. For personal study only.
β¦ Synopsis
The mycotoxin ochratoxin A (OA) consists of 5-chloro-3-methyl-3,4-dihydro-8-hydroxyisocoumarin moiety linked by an amide bond to p-Lphenylalanine. When added to washed rat platelets in vitro, OA caused a dose-dependent inhibition of aggregation induced by agonists such as adenosine diphosphate (ADP) or thrombin. The aggregatory response induced by prior addition of an agonist was also reversed in a dose-dependent manner by OA. Inhibition of aggregation appeared to be irreversible since exposure of platelets to OA followed by several washings removed most of the mycotoxin associated with the platelets but did not diminish the inhibitory response. Serotonin secretion from dense granules and arachidonic acid release from membrane phospholipid (especially phosphatidylcholine) as well as its further metabolism were also inhibited by OA. These results suggest that a disruption of the platelet plasma membrane structure by OA is probably responsible for inhibition of the primary and secondary phases of aggregation.
π SIMILAR VOLUMES
## Abstract Four cyclic peptides, diandrineβ AβD (**1**β**4**), were isolated from the MeOH extract of Formosan __Drymaria diandra.__ Their structures were elucidated by chemical and spectroscopic analyses as cyclo(βGly^1^βPro^2^βTrp^3^βPro^4^βTyr^5^βPhe^6^β), cyclo(βGly^1^βPro^2^βLeu^3^βPro^4^βLeu^
Clinical studies suggest that stent design and surface texture are responsible for differences in biocompatibility of metallic endovascular stents. A simple in vitro experimental setup was established to test stent-induced degree of platelet and leukocyte activation and platelet-leukocyte aggregatio